<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lennon FE</submitter><funding>NCI NIH HHS</funding><pagination>664-75</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4989864</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(11)</volume><pubmed_abstract>Fractals are mathematical constructs that show self-similarity over a range of scales and non-integer (fractal) dimensions. Owing to these properties, fractal geometry can be used to efficiently estimate the geometrical complexity, and the irregularity of shapes and patterns observed in lung tumour growth (over space or time), whereas the use of traditional Euclidean geometry in such calculations is more challenging. The application of fractal analysis in biomedical imaging and time series has shown considerable promise for measuring processes as varied as heart and respiratory rates, neuronal cell characterization, and vascular development. Despite the advantages of fractal mathematics and numerous studies demonstrating its applicability to lung cancer research, many researchers and clinicians remain unaware of its potential. Therefore, this Review aims to introduce the fundamental basis of fractals and to illustrate how analysis of fractal dimension (FD) and associated measurements, such as lacunarity (texture) can be performed. We describe the fractal nature of the lung and explain why this organ is particularly suited to fractal analysis. Studies that have used fractal analyses to quantify changes in nuclear and chromatin FD in primary and metastatic tumour cells, and clinical imaging studies that correlated changes in the FD of tumours on CT and/or PET images with tumour growth and treatment responses are reviewed. Moreover, the potential use of these techniques in the diagnosis and therapeutic management of lung cancer are discussed.</pubmed_abstract><journal>Nature reviews. Clinical oncology</journal><pubmed_title>Lung cancer-a fractal viewpoint.</pubmed_title><pmcid>PMC4989864</pmcid><funding_grant_id>P30 CA014599</funding_grant_id><pubmed_authors>Hensing TA</pubmed_authors><pubmed_authors>Zhang HJ</pubmed_authors><pubmed_authors>Vokes EE</pubmed_authors><pubmed_authors>Murgu SD</pubmed_authors><pubmed_authors>Salgia R</pubmed_authors><pubmed_authors>Vannier MW</pubmed_authors><pubmed_authors>Chen CT</pubmed_authors><pubmed_authors>Cianci GC</pubmed_authors><pubmed_authors>Cipriani NA</pubmed_authors><pubmed_authors>Lennon FE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Lung cancer-a fractal viewpoint.</name><description>Fractals are mathematical constructs that show self-similarity over a range of scales and non-integer (fractal) dimensions. Owing to these properties, fractal geometry can be used to efficiently estimate the geometrical complexity, and the irregularity of shapes and patterns observed in lung tumour growth (over space or time), whereas the use of traditional Euclidean geometry in such calculations is more challenging. The application of fractal analysis in biomedical imaging and time series has shown considerable promise for measuring processes as varied as heart and respiratory rates, neuronal cell characterization, and vascular development. Despite the advantages of fractal mathematics and numerous studies demonstrating its applicability to lung cancer research, many researchers and clinicians remain unaware of its potential. Therefore, this Review aims to introduce the fundamental basis of fractals and to illustrate how analysis of fractal dimension (FD) and associated measurements, such as lacunarity (texture) can be performed. We describe the fractal nature of the lung and explain why this organ is particularly suited to fractal analysis. Studies that have used fractal analyses to quantify changes in nuclear and chromatin FD in primary and metastatic tumour cells, and clinical imaging studies that correlated changes in the FD of tumours on CT and/or PET images with tumour growth and treatment responses are reviewed. Moreover, the potential use of these techniques in the diagnosis and therapeutic management of lung cancer are discussed.</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Nov</publication><modification>2025-04-04T11:54:49.6Z</modification><creation>2019-03-27T02:20:58Z</creation></dates><accession>S-EPMC4989864</accession><cross_references><pubmed>26169924</pubmed><doi>10.1038/nrclinonc.2015.108</doi></cross_references></HashMap>